FcαRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity

Despite the well-recognized involvement of immunoglobulin (Ig) A in mucosal immunity, the function of its receptor, FcαRI (CD89), is poorly understood. The ability of FcαRI to activate leukocytes seems to conflict with the proposed anti-inflammatory activity of secretory IgA. We show here that in a transgenic mouse model, inflammatory mediators induced expression of FcαRI on Kupffer cells, which enabled efficient phagocytosis in vivo of bacteria coated with serum IgA. Secretory IgA did not initiate phagocytosis. Therefore, interactions between serum IgA and FcαRI on Kupffer cells may provide a ‘second line of defense’ in mucosal immunity, by eliminating invasive bacteria entering through the portal circulation and thus preventing disease.

[1]  W. Hartroft.  PHYSIOLOGY IN PATHOLOGY. , 1964, Laboratory investigation; a journal of technical methods and pathology.

[2]  M. Lamm.  Interaction of antigens and antibodies at mucosal surfaces. , 1997, Annual review of microbiology.

[3]  D. Golde,et al.  GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism , 1988, Nature.

[4]  C. March,et al.  Expression cloning of a human Fc receptor for IgA , 1990, The Journal of experimental medicine.

[5]  T. Mayadas,et al.  Human Immunoglobulin A Receptor (FcRI, CD89) Function in Transgenic Mice Requires Both FcR γ Chain and CR3 (CD11b/CD18) , 1999 .

[6]  E. S. Baekkevold,et al.  Regional specialization in the mucosal immune system: what happens in the microcompartments? , 1999, Immunology today.

[7]  S. Wallace,et al.  In vivo microscopy of hepatic metastases: Dynamic observation of tumor cell invasion and interaction with Kupffer cells , 1995, Hepatology.

[8]  P. Artymiuk,et al.  The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity , 1998, Immunology and Medicine Series.

[9]  J. Mestecky,et al.  The human IgA system: a reassessment. , 1986, Clinical immunology and immunopathology.

[10]  C. Kaetzel,et al.  Intracellular neutralization of virus by immunoglobulin A antibodies. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Decker,et al.  Biologically active products of stimulated liver macrophages (Kupffer cells). , 1990, European journal of biochemistry.

[12]  P. Wallace,et al.  Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood. , 1998, Journal of immunology.

[13]  M. Cooper,et al.  Molecular heterogeneity of Fc alpha receptors detected by receptor-specific monoclonal antibodies. , 1992, Journal of immunology.

[14]  C. Maliszewski,et al.  Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. , 1994, Journal of immunology.

[15]  M. Kerr,et al.  The structure and function of human IgA. , 1990, The Biochemical journal.

[16]  D. Bass,et al.  Mechanism of the luminol-dependent chemiluminescence of human neutrophils. , 1982, Journal of immunology.

[17]  M. Russell,et al.  Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL‐8‐stimulated cells , 1995, Journal of leukocyte biology.

[18]  J. Lund,et al.  FcαRI (CD89) as a Novel Trigger Molecule for Bispecific Antibody Therapy , 1997 .

[19]  M. Fanger,et al.  My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. , 1989, Journal of immunology.

[20]  J. V. D. van de Winkel,et al.  Structure and function of human IgA Fc receptors (Fc alpha R). , 1996, Critical reviews in immunology.

[21]  L. Shen,et al.  Monocyte superoxide secretion triggered by human IgA. , 1989, Immunology.

[22]  I. Krukovets,et al.  Enhancement by Tumor Necrosis Factor-α of Fcα Receptor Expression and IgA-Mediated Superoxide Generation and Killing of Pseudomonas aeruginosa by Polymorphonuclear Leukocytes , 1994 .

[23]  M. Daha,et al.  Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). , 1999, Journal of the American Society of Nephrology : JASN.

[24]  J. Mestecky,et al.  IgA antibody as a non-inflammatory regulator of immunity. , 1997, Biochemical Society transactions.

[25]  A. J. Vuuren,et al.  The human Fc receptor for IgA (FcαRI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis , 1999 .

[26]  C. Kaetzel,et al.  A three-tiered view of the role of IgA in mucosal defense. , 1993, Immunology today.

[27]  T. Kodama,et al.  Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice. , 1998, The Biochemical journal.

[28]  J. Oppenheimer,et al.  A Reassessment , 1979 .

[29]  M. Daha,et al.  IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. , 1987, Immunology.

[30]  J. G. Winkel,et al.  Human IgA Fc receptors (FcαR) , 1998 .

[31]  M. Cooper,et al.  Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans , 1990, The Journal of experimental medicine.

[32]  J. Kinet,et al.  The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. , 1999 .

[33]  J. Ravetch.  Fc receptors. , 1997, Current opinion in immunology.

[34]  M. Kerr,et al.  The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. , 1990, Immunology.

[35]  Filip Braet,et al.  Structure and Function of Sinusoidal Lining Cells in the Liver , 1996, Toxicologic pathology.